CLINICAL_TRIALS
trial_result
· 2012-03-19
Clinical Trial Update: Dosing Flexibility Study in Patients With Rheumatoid Arthritis [Phase 4]
Summary
A Phase 4 study evaluating dosing flexibility in patients with rheumatoid arthritis has completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: UCB Pharma | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2012-03-19